|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
TRH e Cancer de mamaFrom: Dr. Sérgio P. Ramos (sergiopr@valley-bbs.com.br)Sun, 16 Mar 1997 12:06:37 -0300
> Prezados colegas: > recebi este e-mail e gostaria de compartilhar com vocjs e posterior > respostas. > Atenciosamente, > Ivone Przepiorka > > Cara Doutora: Gostaria de receber, por favor, informacoes sobre a > terapia de reposicao hormonal. Mais especificamente, gostaria de saber > sobre os riscos de cancer de mama e de obesidade, alem de links sobre o > mesmo tema (TRH). Agradeco muito a sua atencao. Atenciosamente, Maria > Tabosa. Prezada Ivone: Consegui o seguinte: Documents: 1 to 20 of 2957 ------------------------------------------------------------------------
------------------------------------------------------------------------ 1 Nasca PC, et al; Alcohol consumption and breast cancer: estrogen receptor -- ------------------------------------------------------------------------ status and histology. (Am J Epidemiol 1994 Dec 1, Abstract available) [MEDLINE] 2 Zeleniuch-Jacquotte A, et al; Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women. (Cancer Epidemiol Biomarkers Prev 1995 Dec, Abstract available) [MEDLINE] 3 Gilbert L, et al; A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. (J Clin Oncol 1993 Jan, Abstract available) [MEDLINE] 4 Couzi RJ, et al; Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. (J Clin Oncol 1995 Nov, Abstract available) [MEDLINE] 5 Rubin M, et al; 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein. (Cancer Res 1994 Dec 15, Abstract available) [MEDLINE] 6 Cren H, et al; Use of automated smoothing and deconvolution procedures for the determination of human breast cancer estrogen and progesterone receptor isoforms, after high-performance size-exclusion chromatography. (J Chromatogr 1993 May 19, Abstract available) [MEDLINE] 7 Aziz DC, et al; Quantitation and morphometric analysis of tumors by image analysis. (J Cell Biochem Suppl 1994, Abstract available) [MEDLINE] 8 Jordan VC; Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer. (Breast Cancer Res Treat 1995, Abstract available) [MEDLINE] 9 Rochefort H; [Hormonal regulation in breast cancer from cell lines to patients] (Presse Med 1994 Sep 3-10, Abstract available) [MEDLINE] 10 Teixeira C, et al; Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. (Cancer Res 1995 Sep 1, Abstract available) [MEDLINE] 11 Zumoff B; Biological and endocrinological insights into the possible breast cancer risk from menopausal estrogen replacement therapy. (Steroids 1993 May, Abstract available) [MEDLINE] 12 Jeng MH, et al; Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation. (Cancer Res 1992 Dec 1, Abstract available) [MEDLINE] 13 Spicer DV, et al; The prevention of breast cancer through reduced ovarian steroid exposure. (Acta Oncol 1992, Abstract available) [MEDLINE] 14 Yoo KY, et al; A hospital-based case-control study of breast-cancer risk factors by estrogen and progesterone receptor status. (Cancer Causes Control 1993 Jan, Abstract available) [MEDLINE] 15 Catherino WH, et al; The biological action of cDNAs from mutated estrogen receptors transfected into breast cancer cells. (Cancer Lett 1995 Mar 23, Abstract available) [MEDLINE] 16 Herman ME, et al; Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth. (Cancer Res 1994 Nov 15, Abstract available) [MEDLINE] 17 May FE, et al; Estrogen regulated messenger RNAs in human breast cancer cells. (Biomed Pharmacother 1995, Abstract available) [MEDLINE] 18 Liu Y, et al; MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo. (Breast Cancer Res Treat 1995 May, Abstract available) [MEDLINE] 19 Imoto S; [Biological effect of estrogen metabolites in human breast cancer] (Nippon Geka Gakkai Zasshi 1992 May, Abstract available) [MEDLINE] 20 Nomura Y; [Recent progress of endocrine therapy in breast cancer] (Gan To Kagaku Ryoho 1992 Jun, Abstract available) [MEDLINE]
Voltar para Administrador da lista: flavio.monteiro.desouza@obgyn.net Solicitações à lista: obstet-l-request@obgyn.net Última atualização: Mon May 19 16:34:50 2008 |
|
